Bortezomib-Containing Regimens Are Effective in Multiple Myeloma - Results of a Non-Interventional Phase IV Study

Publisher： Karger

E-ISSN： 2296-5262|38|4|167-173

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.4, 2015-03, pp. : 167-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib in Relapsed Multiple Myeloma – Results of a Non-Interventional Study by Office-Based Haematologists

By  

Oncology Research and Treatment, Vol. 32, Iss. 4, 2009-03 ,pp. : 175-180

Karger

Access to resources Recommend Favorite

Bortezomib‐containing induction regimens in transplant‐eligible myeloma patients

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : 4119-4128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Informed consent and phase IV non-interventional drug research

By Bernabe Rosemarie D.C.   van Thiel Ghislaine J.M.W.   van Delden Johannes J.M.   Raaijmakers Jan A.M.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 513-518

Informa Healthcare

Access to resources Recommend Favorite

Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib‐melphalan‐prednisone in the phase III VISTA study

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : 314-319

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term outcomes for newly‐diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 3, 2015-11 ,pp. : 373-377

John Wiley & Sons Inc

Access to resources Recommend Favorite